Bionime Corporation (4737.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4B |
| Enterprise Value | 6.64B |
| P/E Ratio | -14.49 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 2.63 |
| Price/Book Ratio | 2.18 |
| Enterprise/Revenue | 3.95 |
| Enterprise/EBITDA | -44.47 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.17 |
| Operating Margin | -0.18 |
AD
Management Effectiveness
| Return On Assets | -0.05 |
| Return On Equity | -0.14 |
Income Statement
| Revenue | 1.84B |
| Revenue/Share | 21.89 |
| Gross Profit | 627.81M |
| EBITDA | -15.08M |
| Net Income | -180.28M |
| Diluted EPS | -2.65 |
Balance Sheet
| Total Cash | 444.78M |
| Total Cash/Share | 5.67 |
| Total Debt | 2.66B |
| Total Debt/Equity | 1.26 |
| Current Ratio | 0.77 |
| Book Value Per Share | 26.91 |
Price History
| 52-Week Change | -16.81 |
| 52-Week High | 72.9 |
| 52-Week Low | 49.75 |
| Moving Average 50 Days | 57.12 |
| Moving Average 200 Days | 58.22 |
Statistics
| Average Volume | 105,021 |
| Shares Outstanding | 77.29M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1099:1000 |
| Last Split Date | September 08, 2025 |
AD
